Activated Leukocyte Cell Adhesion Molecule Modulates Th2 Immune Response in Atopic Dermatitis

Mi-Seon OH; Jung-Yeon HONG; Mi-Na KIM; Eun-Ji KWAK; Soo-Yeon KIM; Eun-Gyul KIM; Kyung-Eun LEE; Yun-Seon KIM; Hye-Mi JEE; Seo-Hyeong KIM; In-Suk SOL; Chang-Ook PARK; Kyung-Won KIM; Myung-Hyun SOHN.
Allergy, Asthma & Immunology Research ; : 677-690, 2019.
Artículo en Inglés | WPRIM | ID: wpr-762154

Documentos relacionados

  1. CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies.
  2. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
  3. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
  4. Transendothelial Migration of Human B Cells: Chemokine versus Antigen.
  5. Activated Leukocyte Cell Adhesion Molecule: A Novel Regulator of Allergic Inflammation in the Airways.
  6. ALCAM Makes It All Calm by Inhibiting Apoptosis.
  7. MiRNA-192-5p-targeted activated leukocyte cell adhesion molecule improved inflammatory injury of neonatal necrotizing enterocolitis.
  8. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
  9. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers.
  10. ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.